New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 14, 2013
09:33 EDTDOW, CBMCambrex, Dow Chemical collaborate to manufacture drug-solubility solution
Cambrex (CBM) and Dow Chemical (DOW) have executed an agreement for Cambrex to contract manufacture Dow Hydroxypropyl Methylcellulose Acetate Succinate, or HPMCAS, for Drug Solubility Enhancement. Construction has already begun on the new operational facility at Cambrex Karlskoga with commercial product availability set for year-end 2013.
News For CBM;DOW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 26, 2015
10:34 EDTDOWDow AgroSciences targets $1B in revenue from new products by 2018
Subscribe for More Information
February 17, 2015
17:02 EDTDOWSoros Fund Management gives quarterly update on stakes
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use